AIP
ZOM

Ameritas Investment Partners’s Zomedica Corp. ZOM Stock Holding History

Ameritas Investment Partners’s Portfolio ZOM Stock Details ZOM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q2 		– Sell
-2,890
Closed -$1K – 3154
2019
Q1 		$1K Hold
2,890
– – ﹤0.01% 2970
2018
Q4 		$4K Hold
2,890
– – ﹤0.01% 2901
2018
Q3 		$5K Hold
2,890
– – ﹤0.01% 2960
2018
Q2 		$7K Buy
+2,890
New +$5.8K ﹤0.01% 2907

Other funds holding ZOM

Cambridge Investment Research Advisors
Cambridge Investment Research Advisors Fairfield, Iowa $44.6B AUM 28.94% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
PP
Paloma Partners Greenwich, Connecticut $510M AUM 286.05% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Bank of America
Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return
SG Americas Securities
SG Americas Securities New York $179B AUM 65.34% 1-Year Est. Return
JA
JVL Associates Wyoming, Michigan $352M AUM 27.55% 1-Year Est. Return

Ameritas Investment Partners's ZOM Position: Q2 2019 in Review

Ameritas Investment Partners sold out of Zomedica Corp. (ZOM) in Q2 2019, closing a stake of 2,890 shares — an estimated $1K sold.

Ameritas Investment Partners first reported a position in ZOM in Q2 2018 and held it in 4 quarters. The position peaked at $7K in Q2 2018. 28 funds tracked by Wall St. Rank hold ZOM as of Q2 2019.

  • Ameritas Investment Partners reported no remaining Zomedica Corp. position as of Q2 2019 after selling out during the quarter.
  • Ameritas Investment Partners sold 2,890 Zomedica Corp. shares in Q2 2019, an estimated $1K.
  • Ameritas Investment Partners first reported a position in Zomedica Corp. in Q2 2018 and held it in 4 quarters.
  • Ameritas Investment Partners's Zomedica Corp. position peaked at $7K in Q2 2018.
  • 28 funds tracked by Wall St. Rank held Zomedica Corp. as of Q2 2019.

Based on Ameritas Investment Partners's 13F filing for Q2 2019, filed 14 Aug 2019.